• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在产后纳武单抗停药后严重多发性硬化症复发中,进行血浆置换后病情急剧恶化。

Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse.

机构信息

Department of Neurology, MS Clinic, Salpêtrière Hospital, Paris, France.

出版信息

Mult Scler. 2011 Dec;17(12):1520-2. doi: 10.1177/1352458511411064. Epub 2011 Jun 13.

DOI:10.1177/1352458511411064
PMID:21669937
Abstract

We report the case of a young woman with multiple sclerosis who discontinued natalizumab twice and experienced a severe relapse following each natalizumab withdrawal. The first relapse was successfully treated by intravenous methylprednisolone (IVMP). In contrast the second relapse was unresponsive to IVMP. Subsequent treatment by plasma exchanges (PLEX) was followed by a dramatic neurological worsening. This case suggests that PLEX after natalizumab discontinuation may increase relapse severity.

摘要

我们报告了一例多发性硬化症年轻女性患者,她两次停用那他珠单抗,并且在每次停用后都经历了严重的复发。第一次复发通过静脉注射甲基泼尼松龙(IVMP)成功治疗。相比之下,第二次复发对 IVMP 没有反应。随后进行的血浆置换(PLEX)治疗后,神经功能恶化明显加重。该病例提示,那他珠单抗停药后行 PLEX 可能会增加复发的严重程度。

相似文献

1
Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse.在产后纳武单抗停药后严重多发性硬化症复发中,进行血浆置换后病情急剧恶化。
Mult Scler. 2011 Dec;17(12):1520-2. doi: 10.1177/1352458511411064. Epub 2011 Jun 13.
2
Treatment of steroid unresponsive relapse with plasma exchange in aggressive multiple sclerosis.在侵袭性多发性硬化症中采用血浆置换治疗对类固醇无反应的复发
Ther Apher Dial. 2010 Jun;14(3):298-302. doi: 10.1111/j.1744-9987.2009.00794.x.
3
Severe relapse of multiple sclerosis during plasma exchange treatment.多发性硬化症在血浆置换治疗过程中严重复发。
Mult Scler. 2011 Jun;17(6):759-62. doi: 10.1177/1352458511401461. Epub 2011 Mar 22.
4
Paradoxically aggressive multiple sclerosis in the face of natalizumab therapy.面对那他珠单抗治疗时出现的矛盾性侵袭性多发性硬化症。
Mult Scler. 2008 Jun;14(5):708-10. doi: 10.1177/1352458507087135.
5
CD49d expression as a promising biomarker to monitor natalizumab efficacy.CD49d 表达作为监测那他珠单抗疗效的有前途的生物标志物。
J Neurol Sci. 2012 Mar 15;314(1-2):138-42. doi: 10.1016/j.jns.2011.10.005. Epub 2011 Nov 1.
6
Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis.在活跃的复发缓解型多发性硬化症患者中,首次输注那他珠单抗后出现严重复发。
Mult Scler. 2009 Nov;15(11):1359-62. doi: 10.1177/1352458509107011. Epub 2009 Oct 7.
7
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis.意外在妊娠晚期为患有多发性硬化症的青少年患者使用那他珠单抗。
Acta Neurol Scand. 2011 Oct;124(4):290-2. doi: 10.1111/j.1600-0404.2010.01480.x. Epub 2011 Feb 9.
8
Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patients.那他珠单抗和药物假期在临床实践中的应用:一项在非常活跃的复发缓解型多发性硬化症患者中的观察性研究。
J Neurol Sci. 2011 Sep 15;308(1-2):98-102. doi: 10.1016/j.jns.2011.05.043. Epub 2011 Jun 12.
9
Clinical and radiological disease reactivation after cessation of long-term therapy with natalizumab.长期使用那他珠单抗治疗后临床和影像学疾病再激活。
Int J Neurosci. 2012 Jan;122(1):35-9. doi: 10.3109/00207454.2011.622452. Epub 2011 Oct 21.
10
Severe multiple sclerosis relapse under fingolimod therapy: incident or coincidence?芬戈莫德治疗下的严重多发性硬化复发:偶然事件还是巧合?
Neurology. 2012 Mar 20;78(12):928-30. doi: 10.1212/WNL.0b013e31824c46ad. Epub 2012 Mar 7.

引用本文的文献

1
Aggressive multiple sclerosis (2): Treatment.侵袭性多发性硬化症(2):治疗
Mult Scler. 2020 Jun 12;26(9):1352458520924595. doi: 10.1177/1352458520924595.
2
Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation.那他珠单抗治疗中断后出现病情反弹的患者的灾难性结局。
Brain Behav. 2017 Mar 14;7(4):e00671. doi: 10.1002/brb3.671. eCollection 2017 Apr.
3
Rescue of severe brain and cervical cord IRIS by restarting natalizumab in a pregnant MS patient.通过在一名怀孕的多发性硬化症患者中重新使用那他珠单抗挽救严重的脑和颈髓免疫重建炎症综合征。
Neurology. 2017 Feb 14;88(7):711-713. doi: 10.1212/WNL.0000000000003604. Epub 2017 Jan 11.
4
Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort.那他珠单抗停药后复发风险:来自法国TYSEDMUS队列的结果。
Neurol Neuroimmunol Neuroinflamm. 2016 Oct 28;3(6):e297. doi: 10.1212/NXI.0000000000000297. eCollection 2016 Dec.
5
Multiple sclerosis and pregnancy in the 'treatment era'.多发性硬化症与“治疗时代”的妊娠。
Nat Rev Neurol. 2015 May;11(5):280-9. doi: 10.1038/nrneurol.2015.53. Epub 2015 Apr 21.
6
Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients.在高度活跃的多发性硬化症患者中,停用那他珠单抗治疗后临床复发的复发或反弹。
J Neurol. 2014 Jun;261(6):1170-7. doi: 10.1007/s00415-014-7325-8. Epub 2014 Apr 12.
7
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?桥接治疗、转换治疗或药物假期——如何治疗停用那他珠单抗的患者?
Ther Clin Risk Manag. 2013;9:361-9. doi: 10.2147/TCRM.S41552. Epub 2013 Oct 3.